AppRecs review analysis
AppRecs rating 2.3. Trustworthiness 73 out of 100. Review manipulation risk 21 out of 100. Based on a review sample analyzed.
★★☆☆☆
2.3
AppRecs Rating
Ratings breakdown
5 star
20%
4 star
10%
3 star
0%
2 star
20%
1 star
50%
What to know
✓
Low review manipulation risk
21% review manipulation risk
✓
Credible reviews
73% trustworthiness score from analyzed reviews
⚠
Mixed user feedback
Average 2.3★ rating suggests room for improvement
About AnticoagEvaluator
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
AnticoagEvaluator Screenshots
Tap to Rate:
Reviews for AnticoagEvaluator
SDCardioDoc
Useless now.
Since updating to new risk models… the app doesn’t display and actual CHADs-Vasc Score. I understanding what you are going for, but this honestly makes the app less useful and no longer my go-to. Such a shame. Used it for many years and loved it prior to this change.
cdd853
Credible?
Results seem very one-sided. Wonder where funding came from? If results always show same anticoag, why have app?
